Chemical features of peptide selection by the class II histocompatibility molecules

American Journal of Pathology

Volumn 154, Issue 3, 1999, Pages 651-664

  Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EGG WHITE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PEPTIDE; TUMOR NECROSIS FACTOR; HLA ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CONFERENCE PAPER; CYTOKINE RELEASE; HELPER CELL; HEN; HUMAN; IMMUNOGENICITY; INFLAMMATION; LEUKOCYTE; LISTERIA MONOCYTOGENES; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CHEMISTRY; CONFORMATION; IMMUNOLOGY; MOUSE; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICE; MICE, INBRED NOD; MOLECULAR CONFORMATION; PEPTIDES;

EID: 0032999837     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65311-4     Document Type: Conference Paper

References (75)

1. Unanue ER, Allen PM: The basis for the immunoregulatory role of macrophages and other accessory cells. Science 1987, 236:551-557
2. Unanue ER: Studies in Listeriosis show the strong symbiosis between the innate cellular system and the T cell response. Immunol Rev 1997, 158:11-25
3. Buchmeier NA, Schreiber RD: Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci USA 1985, 82:7404-7408
4. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation: Annu Rev Immunol 1996, 14:233-258
5. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy SM: Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549
6. Dalton DK, Pitts MS, Keshav S, Figari I, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993, 259:1739-1742
7. Huang S, Hendricks W, Althage A, Hemmi S, Buethmann H, Kamji R, Vilcek J, Zinkernagel R, Aguet M: Immune response in mice that lack the interferon-γ receptor. Science 1993, 259:1742-1745
8. Mackaness GB: Cellular resistance to infection. J Exp Med 1962, 116:381-390
9. Ziegler K, Unanue ER: Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to lymphocytes. J Immunol 1981, 127:1869
10. Ziegler K, Unanue ER: Decrease in macrophage antigen catabolism by ammonia and chloraquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 1982, 78:175
11. Allen PM, Unanue ER: Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridoma. J Immunol 1984, 132:1077
12. Buus S, Sette A, Grey HM: The interaction between protein-derived immunogenic peptides and la. Immunol Rev 1987, 98:115-141
13. Shimonkevitz R, Kappler J, Marrack P, Grey H: Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med 1983, 158:303-316
14. McDevitt HO, Chinitz A: Genetic control of the antibody response: relationship between immune response and histocompatibility (H-2) type. Science 1969, 163:1207-1210
15. Benacerraf B: Role of MHC gene products in immune regulation Science 1981, 212:1229-1231
16. Rosenthal AS, Shevach EM: Function of macrophages in antigen recognition by guinea pig T lymphocytes. J Exp Med 1973, 138: 1194-1199
17. Katz DH, Hamaoka T, Dorf ME, Maurer Ph, Benacerraf B: Cell interactions between histoincompatible T and B lymphocytes. IV. Involvement of immune response (Ir) gene control of lymphocyte interaction controlled by the gene. J Exp Med 1973, 138:734-740
18. Zinkerragel RM, Doherty PC: Activity of sensitized thymus-derived lymphocytes in lymphocyte choriomeningitis reflects immunological surveillance against altered self components. Nature 1974, 251:547-552
19. Babbitt BP, Allen PM, Matsueda G, Haber E, Unanue ER: Binding of immunogenic peptides to la histocompatibility molecules. Nature 1985, 317:359
20. Babbitt BP, Matsueda G, Haber E, Unanue ER, Allen PM: Antigenic competition at the level of peptide-la binding. Proc Natl Acad Sci USA 1986, 83:4509-4513
21. Luescher IF, Allen PM, Unanue ER: Binding of photoreactive lysozyme peptides to murine histocompatibility class II molecules. Proc Natl Acad Sci USA 1988, 85:871-874
22. d. Proc Natl Acad Sci USA 1984, 81:7564-7568
23. Buus S, Sette A, Colon SM, Miles C, Grey HM: The relation between major histocompatibility complex (MHC) restriction and the capacity of la to bind immunogenic peptides. Science 1987, 235:1353-1358
24. DeLisi C, Berzofsky JA: T-cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci USA 1985, 82:7048-7052
25. Lamb JR, Rees ADM, Bal V, Ikeda H, Wilkinson D, De Vries RRP, Rothbard JB: Prediction and identification of an HLA-DR-restricted T cell determinant in the 19-kd protein of Mycobacterium tuberculosis. Eur J Immunol 1988, 18:973
26. Rammensee H-G, Friede T, Stevanovic S: MHC ligands and peptide motifs: first listing. Immunogenetics 1995, 41:178-228
27. Townsend ARM, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986, 44:959-568
28. Bjorkman PJ, Saper B, Samraoui B, Bennett WS, Strominger JL, Wiley DC: The foreign antigen binding site and T cell recognition regions of class I histocompatibility regions. Nature 1987, 329:512
29. Stern L, Brown G, Jardetsky T, Gorga J, Urban R, Strominger J, Wiley D: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an antigenic peptide from influenza virus. Nature 1994, 368:215
30. Donermeyer DL, Allen PM: Binding to Ia protects an immunogenic peptide from proteolytic degradation. J Immunol 1989, 142:4101-4109
31. Falk K, Rötzschke O, Rammensee H-G: Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 1990, 348:248-251
32. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992, 358:764-768
33. Buus S, Sette A, Colon SM, Grey HM: Autologous peptides constitutively occupy the antigen binding site on la Science 1988, 242:1045-1047
34. Rudensky AY, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr: Sequence analysis of peptides bound to MHC class II molecules. Nature 1991, 353:622-627
35. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH: Characterization of peptides bound to the class I MHC molecule HLA-A2 1 by mass spectrometry. Science 1992, 255:1261-1263
36. c. Science 1992, 256:1817-1820
37. Allen PM, Matsueda GR, Evans RJ, Dunbar JB. Jr, Marshall GR, Unanue ER: Identification of the T-cell and la contact residues of a T-cell antigenic epitope. Nature 1987, 327:713-715
38. Gammon G, Shastri N, Cogswell J, Wilbur S, Sadegh-Nasseri S, Krzych U, Miller A, Sercarz E: The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at, the determinant site. Immunol Rev 1987, 98:53-73
39. k. Proc Natl Acad Sci USA 1992, 89:7380-7383
40. k. Immunol Rev 1996, 151:81-105
41. Lorenz R, Allen PM: Processing and presentation of self-proteins. Immunol Rev 1988, 106:115-127
42. Marrack P, Ignatowicz L, Kappler JW, Boymel J, Freed JH: Comparison of peptides bound to spleen and thymus class II. J Exp Med 1993, 178:2173-2183
43. k. J Immunol 1996, 157:75-762
44. Malnati MS, Marti M, LaVaute T, Jaraquemada D, Biddison W, DeMars R, Long EO: Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 1992, 357:702-704
45. Nelson CA, Petzold SJ, Unanue ER: Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 1994, 371:250-252
46. Germain RN, Hendrix LR: MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 1991, 353:134-139
47. Dornmair K, Rothenhäusler B, McConneli HM: Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harb Symp Quant Biol 1989, 54:409-416
48. Nelson CA, Petzold SJ, Unanue ER: Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc Natl Acad Sci USA 1993, 90:1227-1231
49. Stern LJ, Wiley DC: The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 1992, 68:465-477
50. Carson RT, Vignali KM, Woodland DL, Vignali DA: T cell receptor recognition of MHC class II bound peptide 'lanking residues enhances immunogenicity and results in altered TcR V region usage. Immunity 1997, 7:387-400
51. Dadaglio G, Nelson CA, Deck MB, Petzold SJ, Unanue ER: Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal ant body. Immunity 1997, 6:727-738
52. Lee P, Matsueda GR, Allen PM: T cell recognition of fibrinogen: a determinant on the A α-chain does not require processing. J Immunol 1988, 140:1063-1068
53. Harding CV, Collins DS, Slot JW, Geuze HJ, Unanue ER: Liposomeencapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 1991, 64:393-401
54. Collins DS, Unanue ER, Harding CV: Reduction of disulphide bonds within lysosomes is a key step in antigen processing. J Immunol 1991, 147:4054-4059
55. Parra-Lopez CA, Lindner R, Vidavsky I, Gross M, Unanue ER: Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway. J Immunol 1997, 158:2670-2679
56. Pierre P, Mellman I: Exploring the mechanisms of antigen processing by cell fractionation. Curr Opin Immunol 1998, 10:145-153
57. Cresswell P: Invariant chain structure and MHC class II function. Cell 1996, 84:505-507
58. Lindner R, Unanue ER: Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J 1996, 15: 6910-6920
59. Nelson CA, Vidavsky I, Viner NJ, Gross ML, Unanue ER: Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 1997, 94:628-633
60. Kozono H, While J, Clements J, Marrack P, Kappler JW: Functional soluble major histocompatibility complex proteins with covalently bound peptides. Nature 1994, 369:151-153
61. Fremont D, Hendrickson W, Marrack P, Kappler J: Structures of an MHC class II molecule with covalently bound single peptides. Science 1996, 272:1001-1005
62. k in complex with a dominant epitope of lysozyme. Immunity 1998, 8:305-317
63. Jardetzky T, Gorga J, Busch R, Rothbard J, Strominger J, Wiley D: Peptide binding to HLA-DR1: A simple polyalanine peptide retains MHC binding. EMBO J 1990, 9:1797-1804
64. k a-chain required for the binding and stability of two antigenic peptides. J Immunol 1996, 156:176-182
65. k by using peptide-specific immunoaffinity. J Immunol 1998, 161:6074-6083
66. Lehmann PV, Forsthuber T, Miller A, Sercarz EE: Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992 358:155-157
67. k-restricted determinant of hen egg lysozyme: Limitations of lymph node proliferation studies in defining immunodominance and crypticity. Proc Natl Acad Sci USA 1995, 92:2214-2218
68. Viner NJ, Nelson CA, Deck B, Unanue ER: Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J Immunol 1996, 156:2365-2368
69. Todd JA, Bell JI, McDevitt HO: HLA antigens and insulin-dependent diabetes. Nature 1988, 333:402-411
70. Acha-Orbea H, McDevitt HO: The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc Natl Acad Sci USA 1987, 84:2435-2441
71. + cells of non-obese diabetic mice. J Immunol 1993, 151:1723-1730
72. Shimizu J, Carasco-Marin E, Kanagawa O, Unanue ER: Relationship between β cell injury and antigen presentation in NOD mice. J Immunol 1995, 155:4095-4099
73. g7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 1996, 156:450-458
74. g7-dependent reaction. Proc Natl Acad Sci USA 1998, 95:1721-1724
75. Fairchild PJ, Wildgoose R, Atherton E, Webb S, Wraith DC: An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int Immunol 1993, 5:1151-1158